![]() |
市场调查报告书
商品编码
1858813
营养保健品专用作物市场机会、成长驱动因素、产业趋势分析及预测(2025-2034年)Specialty Crops for Nutraceuticals Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球营养保健品特种作物市场价值为 218 亿美元,预计到 2034 年将以 9.8% 的复合年增长率增长至 566 亿美元。

全球预防保健意识的提升以及对天然植物性健康替代方案的日益青睐,推动了这一领域的扩张。包括营养丰富的水果、种子、坚果、蔬菜和药用草本植物在内的特色作物,因其生物活性和健康益处而备受青睐。这些作物不仅用于功能性食品和膳食补充剂,而且在药物製剂领域也越来越受欢迎,农业与健康科学的交叉领域日益增多。推动这一趋势的因素之一是消费者如今将食物视为药物,并不断寻求针对性的自然长期健康解决方案。人们对被认为具有增强免疫力或缓解压力功效的成分的需求持续激增。近年来,全球健康挑战加剧了这种需求,而精准农业和可控环境栽培等不断发展的农业技术则维持了这一需求,这些技术实现了全年持续收穫。随着政府膳食建议和研究机构强调全食物营养,特色作物在营养保健品领域的角色正日益成为全球健康策略的核心。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 218亿美元 |
| 预测值 | 566亿美元 |
| 复合年增长率 | 9.8% |
到2034年,药用草本植物市场规模将达211亿美元。其广泛应用源自于传统医学体係以及日益增多的科学研究验证。现代消费者越来越倾向于使用草药疗法来缓解压力、增强免疫力并维持长期健康。这个细分市场持续保持领先地位,这得益于消费者群体对天然产品而非合成产品的偏好以及对植物功效的信赖。一些以提升认知功能、增强活力和增强免疫力而闻名的草药品种在膳食补充剂领域呈现爆炸性增长,显着推动了整体市场的扩张。
2024年,膳食补充剂市占率达到65%,预计到2034年将成长至368亿美元。这一增长主要得益于消费者从普通复合维生素转向针对特定健康目标(例如新陈代谢、大脑功能和运动能力)而设计的植物性配方。成分可追溯性、更清晰的标籤和高生物利用度已成为主要的购买驱动因素。领先的膳食补充剂生产商正与特种作物种植者建立策略联盟,以确保产品品质稳定并建立垂直整合的供应链。这有助于确保透明度、永续性和可靠性,而这些正是注重健康的消费者所追求的。
2024年美国营养保健品专用作物市场规模为72亿美元,预计2034年将达到141.6亿美元。该地区受益于尖端农业技术、强大的研发能力以及成熟的高端保健品市场。华盛顿州、俄勒冈州和加利福尼亚州等州正在大力发展以保健为导向的高价值专用作物种植。对有机农业实践和永续发展的推动正在加速种植面积的扩张。美国消费者日益注重健康,他们也越来越需要本地种植、可追溯的成分,这为国内种植者创造了机会,使其能够多元化发展,生产符合高市场标准的植物药和功能性植物基产品。
营养保健品专用作物市场的主要参与者包括凯敏(Kemin)、纽特拉根医疗保健(Neutragen Healthcare)、美洲中心地带(Americas Heartland)、艾瑞斯农业(Aries Agro)和嘉吉(Cargill)。这些公司正优先考虑垂直整合,透过直接投资农业合作来确保稳定、高品质的原材料供应。许多公司正在利用先进的农业技术,例如受控环境农业(CEA)和精准农业,以确保全年供应并提高产量效率。一项重要的策略重点是开发富含特定生物活性成分的专有作物品种,并与临床研究紧密结合,以支持其健康声明。企业正在拓展产品组合,推出针对特定健康目标的清洁标籤、单一成分补充剂。有机、非基因改造和永续农业等认证正被用于差异化产品并建立信任。品牌推广越来越强调可追溯性,企业也在加大研发投入,以将植物功效与可衡量的健康结果连结起来。
The Global Specialty Crops for Nutraceuticals Market was valued at USD 21.8 billion in 2024 and is estimated to grow at a CAGR of 9.8% to reach USD 56.6 billion by 2034.

The expansion is fueled by rising global awareness around preventive health and a growing shift toward natural, plant-based wellness alternatives. Specialty crops, including nutrient-dense fruits, seeds, nuts, vegetables, and medicinal herbs, are being cultivated specifically for their bioactive properties and health benefits. These crops are not only used in functional foods and dietary supplements but are also gaining traction in pharmaceutical formulations, where agriculture increasingly intersects with health science. The momentum is being driven by consumers who now view food as medicine and are increasingly seeking targeted, natural solutions for long-term wellness. Demand continues to surge for ingredients perceived as immune-enhancing or stress-reducing. This interest has been amplified in recent years by global health challenges and is sustained by evolving farming practices like precision agriculture and controlled environment cultivation that allow consistent year-round harvesting. With government dietary recommendations and research institutions emphasizing whole-food nutrition, the role of specialty crops in the nutraceuticals space is becoming central to global wellness strategies.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $21.8 Billion |
| Forecast Value | $56.6 Billion |
| CAGR | 9.8% |
The medicinal herbs and botanicals segment will reach USD 21.1 billion by 2034. Their widespread use stems from both traditional medicine systems and increasing validation from scientific research. Modern consumers are gravitating toward herbal-based remedies for managing stress, boosting immunity, and supporting long-term health. This segment continues to lead, backed by a consumer base that prefers natural over synthetic solutions and trusts botanical efficacy. Several herbal varieties known for supporting cognitive function, energy, and immunity have seen explosive growth in supplement applications, contributing significantly to overall market expansion.
The dietary supplements segment held a 65% share in 2024 and is forecasted to grow to USD 36.8 billion by 2034. This growth is driven by consumers shifting from generic multivitamins to targeted, plant-based formulations designed for specific health outcomes such as metabolism, brain function, and mobility. Ingredient traceability, cleaner labels, and high bioavailability have become major purchase drivers. Leading supplement manufacturers are forming strategic alliances with specialty crop producers to guarantee consistent quality and build vertically integrated supply chains. This helps ensure transparency, sustainability, and reliability, which resonate with health-conscious consumers.
U.S. Specialty Crops for Nutraceuticals Market was valued at USD 7.2 billion in 2024 and is expected to reach USD 14.16 billion by 2034. The region benefits from cutting-edge agriculture technologies, robust research capabilities, and a mature market for premium health products. States like Washington, Oregon, and California are seeing rising cultivation of high-value specialty crops focused on health-based use. The push for organic farming practices and sustainability is accelerating acreage expansion. Health-aware consumers in the U.S. are also increasingly demanding locally grown, traceable ingredients, creating opportunities for domestic growers to diversify into botanicals and functional plant-based products that meet high market standards.
Key players in the Specialty Crops for Nutraceuticals Market include Kemin, Neutragen Healthcare, Americas Heartland, Aries Agro, and Cargill. Companies in the Specialty Crops for Nutraceuticals Market are prioritizing vertical integration by investing directly in farming partnerships to secure consistent, high-quality raw materials. Many are leveraging advanced agricultural practices such as CEA (Controlled Environment Agriculture) and precision farming to ensure year-round availability and enhance yield efficiency. A major strategic focus lies in developing proprietary crop varieties rich in targeted bioactives, aligning closely with clinical research to support health claims. Businesses are expanding product portfolios with clean-label, single-ingredient supplements tailored for specific wellness goals. Certifications such as organic, non-GMO, and sustainably farmed are being used to differentiate offerings and build trust. Branding efforts increasingly highlight traceability, and companies are deepening R&D investment to link botanical efficacy with measurable health outcomes.